Skip to main content
Erschienen in: Child's Nervous System 8/2017

05.04.2017 | Case Report

Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple’s disease: a case report and literature review

verfasst von: Vega Karlowee, Manish Kolakshyapati, Vishwa Jeet Amatya, Takeshi Takayasu, Ryo Nosaka, Kazuhiko Sugiyama, Kaoru Kurisu, Fumiyuki Yamasaki

Erschienen in: Child's Nervous System | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Diffuse leptomeningeal glioneuronal tumor is a new entity under the neuronal and mixed neuronal-glial tumors in the WHO 2016 updated classification and commonly found in children and adolescents. The initial diagnosis is challenging because of its non-specific radiologic feature and negative CSF cytology analysis.

Case summary

A 17 years male was presented with intractable headache subsequently followed by back pain and joint pain. MRI showed enhancement of arachnoid membrane at basal cistern, bilateral sylvian fissure and cerebral cistern with slight enlargement of ventricles. There were no evidences of infection in CSF and blood samples. Based on the duodenal biopsy and prodromal symptom of joint pain, the patient was suspected of having Whipple’s disease. Eleven months after the onset, a small mass lesion was observed at the anterior horn of right lateral ventricle. The histology was remarkable for anaplastic oligodendroglioma. Immunostainings revealed positivity for GFAP, Olig2, synaptophysin and negativity for IDH1 mutation, H3K27M. MIB1 labeling index was 40% and 1p19q FISH analysis showed only 1p deletion. Therefore, a final diagnosis of DLGNT was made.

Conclusion

DLGNT should be included as a differential diagnosis of patients with leptomeningeal-enhanced and high CSF protein level with normal white blood cell count.
Literatur
1.
Zurück zum Zitat Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 131(6):803–820CrossRef Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 131(6):803–820CrossRef
2.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler O, Cavenee WK, Ellison DW, Figarella-Branger D et al (2016) WHO classification of tumours of the central nervous system. Revised 4th ed. International Agency for Research on Cancer (IARC), Lyon Louis DN, Ohgaki H, Wiestler O, Cavenee WK, Ellison DW, Figarella-Branger D et al (2016) WHO classification of tumours of the central nervous system. Revised 4th ed. International Agency for Research on Cancer (IARC), Lyon
3.
Zurück zum Zitat Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D et al (2012) Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol (Berl). 124(5):627–641CrossRef Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D et al (2012) Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol (Berl). 124(5):627–641CrossRef
4.
Zurück zum Zitat Polmeteer FE, Kernohan JW (1947) Meningeal gliomatosis: a study of forty-two cases. Arch Neurol Psychiatr 57(5):593–616CrossRef Polmeteer FE, Kernohan JW (1947) Meningeal gliomatosis: a study of forty-two cases. Arch Neurol Psychiatr 57(5):593–616CrossRef
5.
Zurück zum Zitat Reynolds RM, Boswell E, Hulette CM, Cummings TJ, Haglund MM, Boswell E et al (2011) Sudden death from diffuse leptomeningeal oligodendrogliomatosis. J Neurosurg Spine. 15(6):625–629PubMedCrossRef Reynolds RM, Boswell E, Hulette CM, Cummings TJ, Haglund MM, Boswell E et al (2011) Sudden death from diffuse leptomeningeal oligodendrogliomatosis. J Neurosurg Spine. 15(6):625–629PubMedCrossRef
6.
Zurück zum Zitat Ko MW, Turkeltaub PE, Lee EB, Gonatas NK, Volpe NJ, Moster ML et al (2009) Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis. J Neurol Sci 278(1–2):127–131PubMedCrossRef Ko MW, Turkeltaub PE, Lee EB, Gonatas NK, Volpe NJ, Moster ML et al (2009) Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis. J Neurol Sci 278(1–2):127–131PubMedCrossRef
7.
Zurück zum Zitat Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21(6):1122–1126PubMed Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21(6):1122–1126PubMed
8.
Zurück zum Zitat Mathews MS, Paré LS, Kuo JV, Kim RC (2009) Primary leptomeningeal oligodendrogliomatosis. J Neuro-Oncol 94(2):275–278CrossRef Mathews MS, Paré LS, Kuo JV, Kim RC (2009) Primary leptomeningeal oligodendrogliomatosis. J Neuro-Oncol 94(2):275–278CrossRef
9.
Zurück zum Zitat Leep Hunderfund AN, Zabad RK, Aksamit AJ, Morris JM, Meyer FB, Thorell WE et al (2013) Diffuse anaplastic leptomeningeal oligodendrogliomatosis mimicking neurosarcoidosis. Neurol Clin Pract 3(3):261–265PubMedPubMedCentralCrossRef Leep Hunderfund AN, Zabad RK, Aksamit AJ, Morris JM, Meyer FB, Thorell WE et al (2013) Diffuse anaplastic leptomeningeal oligodendrogliomatosis mimicking neurosarcoidosis. Neurol Clin Pract 3(3):261–265PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Hervey-Jumper SL, Jumper M, Blaivas M, Parmar HA, Robertson PL, Maher CO (2010) Primary diffuse leptomeningeal oligodendroglioma. Pediatr Neurosurg 46(4):326–328PubMedCrossRef Hervey-Jumper SL, Jumper M, Blaivas M, Parmar HA, Robertson PL, Maher CO (2010) Primary diffuse leptomeningeal oligodendroglioma. Pediatr Neurosurg 46(4):326–328PubMedCrossRef
11.
Zurück zum Zitat Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes MBS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg Pediatr. 105(6):465–469CrossRef Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes MBS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg Pediatr. 105(6):465–469CrossRef
12.
Zurück zum Zitat Lyle MR, Dolia JN, Fratkin J, Nichols TA, Herrington BL (2015) Newly identified characteristics and suggestions for diagnosis and treatment of diffuse leptomeningeal glioneuronal/neuroepithelial tumors a case report and review of the literature. Child Neurol Open 2(1):2329048X14567531 Lyle MR, Dolia JN, Fratkin J, Nichols TA, Herrington BL (2015) Newly identified characteristics and suggestions for diagnosis and treatment of diffuse leptomeningeal glioneuronal/neuroepithelial tumors a case report and review of the literature. Child Neurol Open 2(1):2329048X14567531
13.
Zurück zum Zitat Ozkul A, Meteoglu I, Tataroglu C, Akyol A (2006) Primary diffuse leptomeningeal oligodendrogliomatosis causing sudden death. J Neuro-Oncol 81(1):75–79CrossRef Ozkul A, Meteoglu I, Tataroglu C, Akyol A (2006) Primary diffuse leptomeningeal oligodendrogliomatosis causing sudden death. J Neuro-Oncol 81(1):75–79CrossRef
14.
Zurück zum Zitat Schniederjan MJ, Alghamdi S, Castellano-Sanchez A, Mazewski C, Brahma B, Brat DJ et al (2013) Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry. Am J Surg Pathol 37(5):763–771PubMedCrossRef Schniederjan MJ, Alghamdi S, Castellano-Sanchez A, Mazewski C, Brahma B, Brat DJ et al (2013) Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry. Am J Surg Pathol 37(5):763–771PubMedCrossRef
15.
Zurück zum Zitat Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. Case report J Neurosurg 92(1 Suppl):109–113PubMed Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. Case report J Neurosurg 92(1 Suppl):109–113PubMed
16.
Zurück zum Zitat Mittelbronn M, Wolff M, Bültmann E, Nägele T, Capper D, Beck R et al (2005) Disseminating anaplastic brainstem oligodendroglioma associated with allelic loss in the tumor suppressor candidate region D19S246 of chromosome 19 mimicking an inflammatory central nervous system disease in a 9-year-old boy. Hum Pathol 36(7):854–857PubMedCrossRef Mittelbronn M, Wolff M, Bültmann E, Nägele T, Capper D, Beck R et al (2005) Disseminating anaplastic brainstem oligodendroglioma associated with allelic loss in the tumor suppressor candidate region D19S246 of chromosome 19 mimicking an inflammatory central nervous system disease in a 9-year-old boy. Hum Pathol 36(7):854–857PubMedCrossRef
17.
Zurück zum Zitat Rossi S, Rodriguez FJ, Mota RA, Tos APD, Paola FD, Bendini M et al (2009) Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child. Acta Neuropathol (Berl). 118(4):575–577CrossRef Rossi S, Rodriguez FJ, Mota RA, Tos APD, Paola FD, Bendini M et al (2009) Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child. Acta Neuropathol (Berl). 118(4):575–577CrossRef
18.
Zurück zum Zitat Guppy KH, Akins PT, Moes GS, Prados MD (2009) Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. J Neurosurg Spine 10(6):557–563PubMedCrossRef Guppy KH, Akins PT, Moes GS, Prados MD (2009) Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. J Neurosurg Spine 10(6):557–563PubMedCrossRef
19.
Zurück zum Zitat Kessler BA, Bookhout C, Jaikumar S, Hipps J, Lee YZ (2015) Disseminated oligodendroglial-like leptomeningeal tumor with anaplastic progression and presumed extraneural disease: case report. Clin Imaging 39(2):300–304PubMedCrossRef Kessler BA, Bookhout C, Jaikumar S, Hipps J, Lee YZ (2015) Disseminated oligodendroglial-like leptomeningeal tumor with anaplastic progression and presumed extraneural disease: case report. Clin Imaging 39(2):300–304PubMedCrossRef
20.
Zurück zum Zitat Preuss M, Christiansen H, Merkenschlager A, Hirsch FW, Kiess W, Müller W et al (2015) Disseminated oligodendroglial cell-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity. J Neuro-Oncol 124(1):65–74CrossRef Preuss M, Christiansen H, Merkenschlager A, Hirsch FW, Kiess W, Müller W et al (2015) Disseminated oligodendroglial cell-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity. J Neuro-Oncol 124(1):65–74CrossRef
21.
Zurück zum Zitat Gardiman MP, Fassan M, Orvieto E, D’Avella D, Denaro L, Calderone M et al (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20(2):361–366PubMedCrossRef Gardiman MP, Fassan M, Orvieto E, D’Avella D, Denaro L, Calderone M et al (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20(2):361–366PubMedCrossRef
22.
Zurück zum Zitat Cho HJ, Myung JK, Kim H, Park C-K, Kim S-K, Chung CK et al (2015) Primary diffuse leptomeningeal glioneuronal tumors. Brain Tumor Pathol 32(1):49–55PubMedCrossRef Cho HJ, Myung JK, Kim H, Park C-K, Kim S-K, Chung CK et al (2015) Primary diffuse leptomeningeal glioneuronal tumors. Brain Tumor Pathol 32(1):49–55PubMedCrossRef
23.
Zurück zum Zitat Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F et al (2009) Acute hydrocephalus due to secondary Leptomeningeal dissemination of an anaplastic oligodendroglioma. Case Rep Med 2009:e370901 Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F et al (2009) Acute hydrocephalus due to secondary Leptomeningeal dissemination of an anaplastic oligodendroglioma. Case Rep Med 2009:e370901
24.
Zurück zum Zitat Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW et al (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83(1):67–71PubMedCrossRef Gajjar A, Bhargava R, Jenkins JJ, Heideman R, Sanford RA, Langston JW et al (1995) Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 83(1):67–71PubMedCrossRef
25.
Zurück zum Zitat Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol (Berl) 129(4):609–610CrossRef Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A (2015) High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol (Berl) 129(4):609–610CrossRef
26.
Zurück zum Zitat Psarros TG, Swift D, Mulne AF, Burns DK (2005) Neurocytoma-like neoplasm of the thoracic spine in a 15-month-old child presenting with diffuse leptomeningeal dissemination and communicating hydrocephalus. J Neurosurg Pediatr 103(2):184–190CrossRef Psarros TG, Swift D, Mulne AF, Burns DK (2005) Neurocytoma-like neoplasm of the thoracic spine in a 15-month-old child presenting with diffuse leptomeningeal dissemination and communicating hydrocephalus. J Neurosurg Pediatr 103(2):184–190CrossRef
27.
Zurück zum Zitat Yamamoto T, Komori T, Shibata N, Toyoda C, Kobayashi M (1996) Multifocal neurocytoma/gangliocytoma with extensive leptomeningeal dissemination in the brain and spinal cord. Am J Surg Pathol 20(3):363–370PubMedCrossRef Yamamoto T, Komori T, Shibata N, Toyoda C, Kobayashi M (1996) Multifocal neurocytoma/gangliocytoma with extensive leptomeningeal dissemination in the brain and spinal cord. Am J Surg Pathol 20(3):363–370PubMedCrossRef
Metadaten
Titel
Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple’s disease: a case report and literature review
verfasst von
Vega Karlowee
Manish Kolakshyapati
Vishwa Jeet Amatya
Takeshi Takayasu
Ryo Nosaka
Kazuhiko Sugiyama
Kaoru Kurisu
Fumiyuki Yamasaki
Publikationsdatum
05.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 8/2017
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3405-2

Weitere Artikel der Ausgabe 8/2017

Child's Nervous System 8/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.